Unicycive Therapeutics Statistics
Total Valuation
UNCY has a market cap or net worth of $34.27 million. The enterprise value is -$13.94 million.
| Market Cap | 34.27M |
| Enterprise Value | -13.94M |
Important Dates
The next estimated earnings date is Monday, August 12, 2024, after market close.
| Earnings Date | Aug 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
UNCY has 85.68 million shares outstanding. The number of shares has increased by 129.20% in one year.
| Shares Outstanding | 85.68M |
| Shares Change (YoY) | +129.20% |
| Shares Change (QoQ) | +42.27% |
| Owned by Insiders (%) | 7.42% |
| Owned by Institutions (%) | 35.57% |
| Float | 17.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.71
| Current Ratio | 1.71 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -413.97 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -138.90% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.70M |
| Employee Count | 14 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -68.00% in the last 52 weeks. The beta is 2.38, so UNCY's price volatility has been higher than the market average.
| Beta (5Y) | 2.38 |
| 52-Week Price Change | -68.00% |
| 50-Day Moving Average | 0.72 |
| 200-Day Moving Average | 0.91 |
| Relative Strength Index (RSI) | 29.56 |
| Average Volume (20 Days) | 2,095,873 |
Short Selling Information
The latest short interest is 1.47 million, so 1.72% of the outstanding shares have been sold short.
| Short Interest | 1.47M |
| Short Previous Month | 1.20M |
| Short % of Shares Out | 1.72% |
| Short % of Float | 8.55% |
| Short Ratio (days to cover) | 1.33 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -25.78M |
| Pretax Income | -36.93M |
| Net Income | -37.82M |
| EBITDA | -36.32M |
| EBIT | -36.84M |
| Earnings Per Share (EPS) | -$1.19 |
Balance Sheet
The company has $48.93 million in cash and $715,000 in debt, giving a net cash position of $48.22 million or $0.56 per share.
| Cash & Cash Equivalents | 48.93M |
| Total Debt | 715,000 |
| Net Cash | 48.22M |
| Net Cash Per Share | $0.56 |
| Equity (Book Value) | -24.46M |
| Book Value Per Share | -0.29 |
| Working Capital | 21.39M |
Cash Flow
In the last 12 months, operating cash flow was -$20.82 million and capital expenditures -$18,000, giving a free cash flow of -$20.84 million.
| Operating Cash Flow | -20.82M |
| Capital Expenditures | -18,000 |
| Free Cash Flow | -20.84M |
| FCF Per Share | -$0.60 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
UNCY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -129.20% |
| Shareholder Yield | -129.20% |
| Earnings Yield | -110.34% |
| FCF Yield | -60.80% |
Analyst Forecast
The average price target for UNCY is $5.63, which is 1,307.50% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $5.63 |
| Price Target Difference | 1,307.50% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |